Rapid response of omalizumab-resistant chronic urticaria to acalabrutinib

JAAD Case Rep. 2024 Mar 15:47:47-49. doi: 10.1016/j.jdcr.2024.03.004. eCollection 2024 May.

Authors

Diamond R Guy¹, Alicia Mizes², Christopher T Richardson^{2

3}

Affiliations

¹ University of Rochester School of Medicine and Dentistry, Rochester, New York.
² Department of Dermatology, University of Rochester Medical Center, Rochester, New York.
³ Division of Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, New York.

No abstract available

Keywords: Bruton’s tyrosine kinase inhibitor; acalabrutinib; anti-immunoglobulin E autoantibodies; chronic idiopathic urticaria; omalizumab.

Publication types

Case Reports